Shimadzu understands that the development of new pharmaceuticals generally entails two major activities: Drug Discovery and Drug Development. In a Drug Discovery program, the goal is to qualitatively investigate a large number of compounds, narrow the selection through more targeted synthesis and screening (lead optimization), and finally to select potentially viable therapeutic candidates. It is then the responsibility of Drug Development to completely characterize candidate compounds by performing drug metabolism, pre-clinical and clinical screening, clinical trials, QA/QC, and eventually develop a means of manufacturing the final product.
Shimadzu recognizes your needs, and provides analytical tools with a great deal of flexibility in both hardware and software to ensure successful implementation.